Close
  Indian J Med Microbiol
 

Figure 1: (a) Percentage of patients with EBV-DNA positivity in blood in different groupsaP, 0.039, UC versus CD;bP,0.121, refractory UC versus nonrefractory UC;cP, 0.458, refractory CD versus nonrefractory CD Percentage of patients with EBER-1 positive in mucosal in different groups.aP, 0.012, UC versus CD;bP, 0.191, refractory UC versus nonrefractory UC;cP, 0.019, refractory CD versus nonrefractory CD

Figure 1: (a) Percentage of patients with EBV-DNA positivity in blood in different groups<sup>a</sup><i>P</i>, 0.039, UC versus CD;<sup>b</sup><i>P</i>,0.121, refractory UC versus nonrefractory UC;<sup>c</sup><i>P</i>, 0.458, refractory CD versus nonrefractory CD  Percentage of patients with EBER-1 positive in mucosal in different groups.<sup>a</sup><i>P</i>, 0.012, UC versus CD;<sup>b</sup><i>P</i>, 0.191, refractory UC versus nonrefractory UC;<sup>c</sup><i>P</i>, 0.019, refractory CD versus nonrefractory CD